MAK — MATERNUS-Kliniken-AG Cashflow Statement
0.000.00%
- €24.33m
- €124.18m
- €114.00m
Annual cashflow statement for MATERNUS-Kliniken-AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -7.78 | -1.96 | -12.8 | -12.6 | -10.3 |
Depreciation | |||||
Non-Cash Items | 6.71 | 6.76 | 4.35 | 7.08 | 11.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.64 | 1.33 | 1.79 | -1.72 | 1.66 |
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 12.2 | 17.2 | 4.33 | 2.52 | 15.1 |
Capital Expenditures | -0.736 | -1.93 | -2 | -3.96 | -1.22 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.034 | 0.008 | 0.002 | 0 | 0.143 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.702 | -1.92 | -2 | -3.96 | -1.07 |
Financing Cash Flow Items | -7.05 | -5.99 | -5.77 | -7.53 | -4.29 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.23 | -12.8 | -12.8 | -0.069 | -11.7 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.24 | 2.54 | -10.4 | -1.51 | 2.33 |